Isotope labelled Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in
Molecular Weight:
423.4
Form:
Supplied as a Off-White to Pale Beige Solid
* VAT and and shipping costs not included. Errors and price changes excepted
